Healthcare Experience


Our Healthcare experience includes 812 clients, with 75 partnered brands and 759 USAN/INN names. Below is our extensive portfolio, feel free to filter by clients, brands, category or USAN/INN Names.   ||  Click Here for Consumer/B2B Experience



CLIENTS BRANDS CATEGORY
DOW PHARMACEUTICAL SCIENCES ACANYA Dermatology
DENDREON ACI Class Name
DERMA SCIENCES aclerastide Dermatology
DART NEUROSCIENCE adarigiline Neurology
DR. REDDY'S LAB AIMI Technology Name
DAIICHI-SANKYO ALDAY Clinical Trial Name
DOMPE ALLOGENEIC TRANSPLANTATION Clinical Trial Name
DERMIRA ATMOS-1 Clinical Trial Name
DERMIRA ATMOS-2 Clinical Trial Name
DOMPE AUTOLOGOUS TRANSPLANTATION Clinical Trial Name
DAIICHI-SANKYO AZOR Cardiovascular
DAIICHI-SANKYO BENICAR * Cardiovascular
DAIICHI-SANKYO BENICAR HCT * Cardiovascular
DERMIK LABORATORIES BENZACLIN Dermatology
DUCHESNAY BONJESTA Gastrointestinal
DERMIK LABORATORIES CARAC Dermatology
DERMIRA CIMPACT Clinical Trial Name
DERMIRA CIMPASI-1 Clinical Trial Name
DERMIRA CIMPASI-2 Clinical Trial Name
DURATA THERAPEUTICS DALVANCE * Antibiotic
DELENEX THERAPEUTICS DELENEX THERAPEUTICS Corporate Identity
DAIICHI-SANKYO EFFIENT Cardiovascular
DAIICHI-SANKYO EFIENT (エフィエント) Cardiovascular
DOW PHARMACEUTICAL SCIENCES efinaconazole Antifungal
DAIICHI-SANKYO ENGAGE AF Clinical Trial Name
DAIICHI-SANKYO firuglipel Endocrinology
DAIICHI-SANKYO FLOXIN OTIC Antibiotic
DAIICHI-SANKYO FLOXIN OTIC SINGLES * Antibiotic
DEPOMED GRALISE Pain & Inflammation
DR. REDDY'S LAB HANZEMA * Immunology
DYNAVAX TECHNOLOGIES HEPLISAV-B * Vaccine
DR. REDDY'S LAB HERVYCTA Oncology
DR. FALK PHARMA JORVEZA Gastrointestinal
DYAX lanadelumab Pain & Inflammation
DENDREON lapuleucel-t Oncology
DAIICHI-SANKYO LIXIANA Cardiovascular
DUCHESNAY MICTORYL * Nephrology
DUCHESNAY MICTORYL PEDIATRIC * Nephrology
DAIICHI-SANKYO milademetan Oncology
DR. REDDY'S LAB MINOLIRA * Dermatology
DAIICHI-SANKYO MOBIC Pain & Inflammation
DELIVERY TECHNOLOGIES MORPHABOND * Pain & Inflammation
DJO GLOBAL MOVATION Medical Device
DOUGLAS PHARMS MYORISAN * Dermatology
DAIICHI-SANKYO NEUCOURSE Clinical Trial Name
DERMIRA olumacostat glasaretil Dermatology
DAKO OMNIS Medical Device
DOMPE OXERVATE Ophthalmology
DAIICHI-SANKYO patritumab Oncology
DERMIK LABORATORIES PENLAC * Antifungal
DRAGER PERSEUS Medical Device
DAIICHI-SANKYO pexidartinib Oncology
DAIICHI-SANKYO PRASFIT Clinical Trial Name
DAIICHI-SANKYO PRASTRO Clinical Trial Name
DENDREON PROVENGE Oncology
DERMIRA QBREXZA * Dermatology
DAIICHI-SANKYO QUIXIN * Ophthalmology
DAIICHI-SANKYO REDUCER Clinical Trial Name
DOMPE REPARO Clinical Trial Name
DAIICHI-SANKYO REZALTAS Cardiovascular
DAIICHI-SANKYO ROTEAS Cardiovascular
DAIICHI-SANKYO SAVAYSA * Cardiovascular
DAIICHI-SANKYO SEVIKAR Cardiovascular
DENDREON sipuleucel-t Oncology
DISCOVERY LABS SURFAXIN Respiratory
DAIICHI-SANKYO TARLIGE Neurology
DNATRIX THERAPEUTICS tasadenoturev Oncology
DAIICHI-SANKYO tivantinib Oncology
DAIICHI-SANKYO TRIBENZOR Cardiovascular
DENTSPLY SIRONA TRUNATOMY Medical Device
DAIICHI-SANKYO TURALIO * Oncology
DAIICHI-SANKYO VANFLYTA (ヴァンフリタ) * Oncology
DOUGLAS PHARMS VERSACLOZ * Neurology
DAIICHI-SANKYO WELCHOL * Cardiovascular
DURATA THERAPEUTICS XYDALBA (Ксидалва) * Antibiotic


* Denotes a comprehensive report of the safety regulatory research prepared by BI/DSI for submission of this name candidate to FDA, EMA, Health Canada, JMHLW, ANVISA, ROSZDRAVNADZOR, CDSCO, CFDA, KOREA MFDS, and/or other Regulatory Agencies.

Back to top